Pacemaker-associated thrombosis in ongoing therapy with edoxaban tosylate
| Autor: | Roberto Mioni, Alessandro Rizzo, Lucia Russo, Angelo Di Vincenzo |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Pacemaker
Artificial medicine.medical_specialty Pyridines 030204 cardiovascular system & hematology 03 medical and health sciences chemistry.chemical_compound Anticoagulation 0302 clinical medicine Edoxaban Antithrombotic medicine Humans 030212 general & internal medicine Intensive care medicine Pacemaker Thrombosis business.industry Hematology medicine.disease Thiazoles chemistry Echocardiography Oral anticoagulant Diagnostic assessment Cardiology and Cardiovascular Medicine Complication business Edoxaban tosylate Factor Xa Inhibitors Thrombosis prevention |
| Popis: | Thromboembolism is a known complication of pacemaker implantation. However, published literature describes only a few cases, in which the events occurred in absence of antithrombotic prophylaxis, not routinely employed for its prevention in current clinical practice. We report a case of pacemaker lead-associated thrombosis in a patient taking continuative oral anticoagulant therapy with edoxaban tosylate (edoxaban). No data in present literature supports the use of anticoagulant prophylaxis for pacemaker lead thrombosis. In our report ongoing treatment with edoxaban proved ineffective for thrombosis prevention. We also discuss the role of three-dimensional transthoracic echocardiography for diagnostic assessment of thrombosis in a fragile patient. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|